Gesynta Pharma AB, a clinical-stage biotech company developing vipoglanstat, a non-hormonal, non-opioid therapy that could transform the standard of care...
Nouscom, a clinical-stage, cancer interception focused biotech developing next-generation immunotherapies, today announced the closing of an oversubscribed €120 million ($135...
iOnctura, a clinical-stage precision oncology company combating neglected and hard-to-treat cancers, today announces the appointment of Paul Sekhri as Chair...
iOnctura, a clinical-stage precision oncology company combating neglected and hard-to-treat cancers, today announced the publication of two peer-reviewed articles in...
Aptadir Therapeutics (Aptadir), a biotech company developing a novel class of RNA inhibitor-based therapeutics for treating intractable genetic conditions, announces...
Dialybrid S.r.l. (Dialybrid), a privately held medical device company developing a novel vascular access solution for hemodialysis based on Silkothane®,...
Genespire, an Italian biotechnology company focused on developing gene therapies for severe pediatric genetic diseases, has today announced the commencement...
Focalis Bio, a biotechnology company focused on research and development of cutting-edge gene therapies to treat refractory epilepsy, today announced...
Tes Pharma, a biopharmaceutical company focused on developing first-in-class therapeutics for high unmet medical needs in renal diseases, announced today...